Biology subjects

Inada, M.

Publications and source records attributed to Inada, M..

3 recordsLinked to original sources

bioRxiv2026

Compact serum miRNA qPCR model for pancreatic cancer discrimination with independent and clinical validation

BackgroundFor pancreatic cancer, practical blood-based tests for early detection and postoperative surveillance remain elusive. We sought to develop a qPCR-measurable serum microRNA (miRNA) panel that robustly discriminates pancreatic cancer from non-cancer controls and other malignancies. MethodsWe profiled 255 serum miRNAs in batch 1 (n=72) and selected 27 candidates. Candidates were refined in batch 2 (n=552) and cross-batch evaluation was performed with batch 3 (n=391) to derive a miRNA model. Independent validation used batch 4 (n=616). Clinical relevance was assessed in an independent clinical cohort of resection patients with samples obtained preoperatively and at 1 and 12 months postoperatively. ResultsThe miRNA model trained on batches 2 and 3 achieved an area under the curve (AUC) of 0.91 and 0.83 for pancreatic cancer versus non-cancer controls and non-cancer plus other cancers, respectively, when independently validated in batch 4. Stage-wise AUCs in batch 4 were 0.91 (I), 0.94 (II), 0.86 (III) and 0.90 (IV). In the clinical batch, the score decreased postoperatively (preoperative vs month 1; p<0.01) and was higher in recurrence than non-recurrence (p<0.001). ConclusionsThe developed compact miRNA qPCR assay discriminated pancreatic cancer across independent assay batches and showed clinical relevance for postoperative surveillance. Clinical Trial RegistrationNot applicable.

cancer biology↗

bioRxiv2022

Binding of cardiolipin to the KcsA channel at the membrane outer leaflet allosterically opens the inner gate

Membrane proteins embedded in the membrane undergo changes in their actions under the influence of membrane lipids. Here, we present a novel type of lipid action on the potassium channel KcsA from Streptomyces lividans. Cardiolipin is present in various cellular membranes, including the host membrane of KcsA. Although the M0 domain, a nontransmembrane helix, is known to sense anionic lipids in the inner leaflet, we found that divalent anionic cardiolipin in the outer leaflet of the membrane interacts with positively charged residues, Arg64 and Arg89, on the extracellular side of the transmembrane domain. This binding propagates its action across the membrane toward the intracellular region of KcsA, thus, opening the inner gate. Such a long-range allosteric effect has not been found for channel-lipid interactions.

biophysics↗

bioRxiv2020

An SNP variant MT1-MMP with a defect in its collagenolytic activity confers the fibrotic phenotype of Dupuytren's Disease

Dupuytrens Disease (DD) is a common fibroproliferative disease of the palmar fascia. We previously identified a strong association with a non-synonymous variant (rs1042704, pD273N) in MMP14 (encoding MT1-MMP). We investigated the functional consequences of this variant, and demonstrated that the variant MT1-MMP (MT1-N273) exhibits only 17% of cell surface collagenolytic activity compared to the ancestral enzyme (MT1-D273). Cells expressing both MT1-D273 and MT1-N273 in a 1:1 ratio, mimicking the heterozygous state, possess 38% of the collagenolytic activity compared to the cells expressing MT1-D273, suggesting that MT1-N273 acts in a dominant negative manner. Consistent with this hypothesis, patient-derived DD myofibroblasts expressing MT1-N273 demonstrated around 30% of full collagenolytic activity regardless of the heterozygous or homozygous state. 3D-molecular envelope modelling using small angle X-ray scattering demonstrated altered positioning of the catalytic domain within dimeric molecules. Taken together, our data suggest that rs1042704 directly contributes to the fibrotic phenotype of DD.

biochemistry↗